Clinical Characteristics, Interventions and Adverse Outcomes of Acute Lower Gastrointestinal Bleeding: A Cohort Study Conducted in Vietnam

越南一项队列研究:急性下消化道出血的临床特征、干预措施及不良结局

阅读:1

Abstract

BACKGROUND AND AIM: Despite medical advances, the incidence of acute lower gastrointestinal bleeding (ALGIB) is gradually increasing in Asia and Vietnam, with many cases being severe. However, recent data on clinical features, interventions, and outcomes in Vietnam remain limited. This study aims to characterize the presentation, treatment, and outcomes of ALGIB in Vietnamese patients. METHOD: A retrospective and prospective cohort study was conducted on 222 patients aged 18 years and older with ALGIB at the Department of Gastroenterology, University Medical Center Ho Chi Minh City. Clinical characteristics, interventions, and adverse outcomes were recorded. RESULTS: A total of 222 patients were included in the study, with a female-to-male ratio of 1.02 and a mean age of 63.7 years. Among them, 85.6% were admitted with symptoms of bright red blood per rectum, maroon-colored stool, or stool with clots. The most common causes of acute lower gastrointestinal bleeding were hemorrhoids (20.7%) and colonic diverticulosis (20.3%). The rates of blood transfusion, endoscopic intervention, radiologic intervention, and surgery were 38.7%, 19.4%, 2.7%, and 2.7%, respectively. Severe lower gastrointestinal bleeding was observed in 59 patients (26.6%). There were two in-hospital deaths (0.9%), one related to underlying comorbidities and one due to persistent, uncontrollable bleeding. CONCLUSION: Hemorrhoids were the most common cause of acute lower gastrointestinal bleeding. The rates of blood transfusion, endoscopic intervention, radiologic intervention, and surgery were 38.7%, 19.4%, 2.7%, and 2.7%, respectively. Overall, 26.6% of cases progressed to severe lower gastrointestinal bleeding.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。